ArticleProceedings of the National Academy of Sciences of the United States of America2026

A modified CRISPR/Cas9 approach in silencing the triplication in Down syndrome: A treatment path XISTs.

Gewei Lian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.